eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Eli Lilly and Company Limited
Lilly House, Priestley Road, Basingstoke, Hampshire, RG24 9NL
Telephone: +44 (0)1256 315 000
Fax: +44 (0)1256 775 858
WWW: http://www.lilly.co.uk
Medical Information e-mail: ukmedinfo@lilly.com
Medical Information Fax: +44 (0)1256 775 569

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 07/12/2011
PIL Prozac 20mg hard capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 07/12/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 27/09/2011 and displayed until 07/12/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 10/06/2011 and displayed until 27/09/2011
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change to date of revision
Updated on 11/11/2010 and displayed until 10/06/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to information about pregnancy or lactation
Updated on 26/07/2010 and displayed until 11/11/2010
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to date of revision
  • Change to side-effects
  • Change to information about pregnancy or lactation
Updated on 24/04/2009 and displayed until 26/07/2010
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 30/10/2008 and displayed until 24/04/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change due to user-testing of patient information
Updated on 27/06/2008 and displayed until 30/10/2008
Reasons for adding or updating:
  • Change to side-effects
  • Introduction of new pack/pack size
  • Change to date of revision
Updated on 02/05/2008 and displayed until 27/06/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 11/01/2008 and displayed until 02/05/2008
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
  • Change to date of revision
Updated on 31/07/2007 and displayed until 11/01/2008
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 19/02/2007 and displayed until 31/07/2007
Reasons for adding or updating:
  • Changes to therapeutic indications
  • Change to how to administer the medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to storage instructions
  • Change to manufacturer contact details
  • Change to date of revision
Updated on 03/02/2006 and displayed until 19/02/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 16/01/2004 and displayed until 03/02/2006
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 16/01/2004 and displayed until 16/01/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 14/12/2000 and displayed until 16/01/2004
Reasons for adding or updating:
  • No reasons supplied
Updated on 06/03/2000 and displayed until 14/12/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  fluoxetine hydrochloride